The Drug Abuse Warning Network (DAWN) 2022 Findings on Drug-Related Emergency Related Visits presents national estimates of drug- related...
Archive for category: Research & Publications
The International Narcotic Control Board (INCB) recently published the 2022 Precursors Annual Report, which describes trends in the trade...
US: Vital Statistics Rapid Release: Provisional drug overdose death counts

Earlier this week, the CDC released updated provisional drug overdose death counts based on data from the National Vital...
US: CDC issues new opioid prescribing guidance, giving doctors more leeway to treat pain

The Centers for Disease Control and Prevention has issued new guidance for clinicians on how and when to prescribe...
US: Meaning of “Good Faith” Efforts under Controlled Substances Act Determined by U.S. Supreme Court

U.S. Supreme Court Ruling – “Good Faith” As reported by LAPPA (August 2022) Xiulu Ruan v. United States, U.S....
US: Bromazolam Prevalence Surgining Across the United States

NPS Discovery would like to notify you about new information regarding the new benzodiazepine Bromazolam. Identifications for this benzodiazepine...
How a Large AMC Took a Proactive Approach to Drug Diversion Monitoring

by Amanda Rogers, Marketing Content Writer, Protenus on June 14, 2022 Detecting and monitoring drug diversion using manual processes and disjointed...
US: Online “Nootropics” Sellers Sentanced for Selling Misbranded and Unapproved Drugs

U.S. District Court Ruling – Misbranded & Unapproved Drugs – Tianeptine As reported by LAPPA (August 2022) United States...
VA: Hospital Settles Controlled Substance Act Violations for $4.36 Million

U.S. District Court Ruling – Misbranded & Unapproved Drugs – Tianeptine As reported by LAPPA (August 2022) In Re:...
US: Preliminary Findings from Drug-Related Emergency Department Visits, 2021 (DAWN)

An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related...